Heart Test Laboratories, Inc. (HSCS)
Last Price$2.95.0%
Market Cap$2,541.3M
HSCS Rating
HSCS Quality rating performance
HSCS Intrinsic Value
Key Highlights:
As of Mar 11, 2025 HSCS Relative Value is $1.2, which is overvalued by 57.3%, compared to current share price of $2.9.
As of Mar 11, 2025 HSCS DCF Value is $639.5, which is undervalued by 21,799.3%, compared to current share price of $2.9.
HSCS Share Price History
1W (8.8%)
1M (23.6%)
6M 3.5%
YTD (82.5%)
1Y (75.8%)
3Y (98.3%)
5Y (98.3%)
10Y (98.3%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
HSCS Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$2,541.3M
$1,392.8M
$14.7K
($4,209.2M)
Shares Outstanding
870M
Employees
N/A
Growth (CAGR)
N/A
N/A
168.8%
(50.27%)
Profitability
(245.6%)
(50,788.2%)
(51,867.9%)
(28,611,889.3%)
(28,634,171.0%)
101.7%
Intrinsic Value
$337.2 (11,448.4% undervalued)
$673.1
$1.3
$312.9
(100.0%)
(2.3%)
Valuation (LTM)
Return on Capital
(83,172.2%)
(51,827.8%)
(1.3%)
0.5%
(2,393.8%)
(953.6%)
(953.6%)
Financial Health
$4,052.1M
($1,148.5M)
0.3x
(26.7x)
72,288.9%
Dividends
Earnings
Jan 01, 1970
MISS by 0.0%
BEAT by (1.3%)
(10.3%)
2 Beat & 8 Miss
HSCS Stock Financials
HSCS Income Statement Metrics
Annual
Quarterly
LTM
HSCS Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($6,070.2K) +5.1% YoY
Capital Expenditure (CAPEX)
($125.3K) -98.3% YoY
Free Cash Flow (FCF)
($6,195.5K) -52.5% YoY
HSCS Income Statement Overview
Annual
Quarterly
LTM
Apr'20
Apr'21
Apr'22
Apr'23
Apr'24
$18.6K 261.2% YoY
Cost of revenue
$6,081.0 117.5% YoY
Operating
expenses
$6,318.3K 3.3% YoY
Other: $6,605.2K
HSCS Balance Sheet Overview
Annual
Quarterly
LTM
Apr'20
Apr'21
Apr'22
Apr'23
Apr'24
Assets
Liabilities
Total assets
$9,503.1K
Current assets ($7,353.9K, 77.4% of total)
$5,807.6K (61.1%)
$0.0 (0.0%)
Other current assets
$1,546.2K (16.3%)
Non-current assets ($2,149.2K, 22.6% of total)
$0.0 (0.0%)
$560.0K (5.9%)
$1,589.2K (16.7%)
Other non-current assets
$0.0 (0.0%)
Financial position
($4,771.3K)
Cash & Short-term
Investments
Total Debt
HSCS Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
HSCS Earnings Surprises
Crunching data... Almost there!
HSCS Dividends
HSCS Dividend Yield
Crunching data... Almost there!
HSCS Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with HSCS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$2,541.3M | 5.4 | $337.2 11,448.4% undervalued | (75.8%) | $14.7K | ($4,209.2M) | (99.7%) | (28,634,171.0%) | (245.6%) | (1.3%) | 72,288.9% | |
$231.4B | 7.0 | $178.1 34.3% undervalued | 12.6% | $42.0B | $6,351.0M | 4.6% | 15.1% | 55.6% | 25.3% | 31.4% | |
$140.4B | 6.8 | $36.4 61.9% overvalued | 44.5% | $16.7B | $2,438.0M | 17.6% | 14.6% | 67.0% | 8.0% | 50.7% | |
$139.3B | 6.5 | $300.2 17.8% overvalued | 3.7% | $22.6B | $3,487.0M | 10.2% | 15.4% | 62.8% | 10.4% | 65.9% | |
$119.7B | 6.4 | $117.2 25.6% undervalued | 12.8% | $33.2B | $5,467.0M | 2.7% | 16.5% | 62.9% | 7.4% | 53.6% | |
$40.4B | 6.2 | $54.2 20.8% overvalued | (24.7%) | $5,724.3M | $289.9M | (4.7%) | 5.1% | 78.4% | 21.6% | 7.0% | |
$28.0B | 7.3 | $39.4 43.9% overvalued | (47.2%) | $4,033.0M | $630.7M | 11.3% | 15.6% | 60.4% | 21.7% | 120.3% | |
$24.6B | 5.3 | $69.4 159.4% undervalued | 29.2% | €18.0B | €1,145.0M | (0.8%) | 6.4% | 43.1% | (4.2%) | 63.4% | |
$22.6B | 6.4 | $194.8 14.6% overvalued | (1.5%) | $5,398.4M | $751.4M | (0.2%) | 13.9% | 44.7% | 8.2% | 35.6% | |
$21.8B | 5.8 | $178.8 66.6% undervalued | (15.4%) | $7,678.6M | $1,132.4M | 3.8% | 14.7% | 66.0% | 6.3% | 43.0% | |
$17.2B | 7.9 | $104.8 57.3% overvalued | 35.4% | $1,900.3M | $303.0M | 12.0% | 15.9% | 76.4% | 26.9% | 6.9% |
FAQ
What is Heart Test Laboratories, Inc. (HSCS) stock rating?
As of today, Heart Test Laboratories, Inc. has a stock rating of 5 (out of 10), which is considered Good.
is Heart Test Laboratories, Inc. (HSCS) a good stock to buy?
As of today, Heart Test Laboratories, Inc. has a Good stock rating, which is 11,448.4% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.